文献速递临床试验与 GCP基础与转化研究

基于影像与基于阈值评估的帕金森病脑深部电刺激程控:随机对照试验研究方案

Imaging-based versus threshold assessment-based deep brain stimulation programming in Parkinson's disease: study protocol for a randomized controlled trial {1a}.
PubMed 文献 · Trials · 2026-06-26

该研究为单中心前瞻性随机开放盲终点试验,计划纳入132例接受丘脑底核脑深部电刺激的帕金森病患者,比较基于影像的触点选择与常规单极复查阈值评估在选择触点治疗运动症状方面的非劣效性,主要终点为关药状态下MDS-UPDRS第三部分评分从基线至6个月的平均变化。

要点

  • 影像组利用术前7T MRI与术后CT构建患者特异性3D解剖模型,模拟组织激活体积并选择与运动亚区对齐的触点。
  • 主要终点为关药状态下MDS-UPDRS第三部分评分从基线至6个月的平均变化。
  • 次要终点涵盖运动症状、异动症、非运动症状、生活质量、不良事件、程控时长及交叉换组等。

核心结论

  • 该试验旨在评估基于影像的DBS程控触点选择在改善运动症状方面是否非劣效于常规单极复查阈值评估法。

研究设计与样本

  • 单中心、前瞻性、随机、开放标签、盲终点评估的对照试验,采用PROBE设计。
  • 计划纳入132例接受丘脑底核脑深部电刺激的帕金森病患者,随机分为影像组和阈值组。
  • 随访时间为初始程控后6个月。

关键数值与推荐

  • 主要终点为关药状态下MDS-UPDRS第三部分评分从基线至6个月的平均变化。
  • 影像组触点选择基于术前7T MRI和术后CT构建的患者特异性3D解剖模型,可视化丘脑底核并模拟与运动亚区对齐的组织激活体积。
  • 阈值组采用常规单极复查进行触点选择。

临床怎么用

  • 若影像法非劣效成立,可能为DBS程控提供更高效、快速且刺激设置更稳定的触点选择途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) effectively treats motor fluctuations in Parkinson's disease. The clinical outcome depends on optimal programming, which involves selecting active contacts and adjusting stimulation parameters to maximize clinical benefit while minimizing adverse effects. The conventional clinically guided approach, the monopolar review (MPR), is complex and time-consuming due to numerous parameter combinations, interindividual anatomical variability, and differences in DBS lead placement. Recent advances in neuroimaging offer the potential to guide contact selection based on patient-specific anatomy. METHODS: A single-centre, prospective, randomized, open-label trial with blinded endpoint assessment (PROBE design) is being conducted in patients with Parkinson's disease undergoing STN-DBS to determine whether imaging-based contact selection is non-inferior to the current standard MPR for contact selection in treating motor symptoms. A total of 132 patients are randomized to either imaging-based programming (Imaging group) or threshold-assessment-based programming (i.e., MPR, Threshold group). In the Imaging group, contacts are selected using patient-specific 3D anatomical models derived from preoperative 7 T MRI and postoperative CT, visualizing the STN and simulating volumes of tissue activated (VTA) aligned with the motor subdivision. The primary outcome is the mean change from baseline to 6 months in the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III score during the off-drug phase. Secondary outcomes include motor symptoms in the on-medication phase, duration of off-medication time, dyskinesia severity and duration, non-motor symptoms, motor aspects of daily living, physical disability, disease-specific quality of life, (severe) adverse effects, treatment satisfaction and burden, crossover to the alternate programming arm, use of care, programming duration, final DBS settings, and concordance between 6-months stimulation contacts and initial selections. Follow-up is 6 months after initial programming. DISCUSSION: The trial evaluates whether imaging-based DBS programming can achieve motor improvements comparable to clinical threshold-assessment-based programming, while potentially offering greater efficiency, speed, and stability of stimulation settings. Although the study is designed as a non-inferiority trial, we hypothesize that imaging-based contact selection may ultimately provide a superior approach by enabling faster optimization with fewer parameter adjustments. TRIAL REGISTRATION: The DBS-ITAP trial was registered at clinicaltrials.gov (NCT06223399) on January 23, 2024, https://clinicaltrials.gov/study/NCT06223399 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van der Weide A, Wiggerts Y, Beudel M, et al. Imaging-based versus threshold assessment-based deep brain stimulation programming in Parkinson's disease: study protocol for a randomized controlled trial {1a}. Trials. 2026. PMID: 42363278. doi:10.1186/s13063-026-09870-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。